ImmunGene, Inc. 
ImmunGene is leveraging promising science to empower therapeutic antibodies with immune molecules. These molecules are highly optimized for dramatic efficacy and a superior safety profile.
Our technology allows us to genetically engineer cytotoxic cytokines to antibodies to selectively target disease causing cells and tissues while reducing the systemic toxicity of the cytokines. ImmunGene has several antibody molecules genetically engineered with interferon for following indications:
Non-Hodgkins lymphoma
Leukemia
Multiple myeloma
Melanoma
Renal cancer
Prostate cancer
Breast Cancer
